![](/img/cover-not-exists.png)
P-087A phase II study of a combination treatment of alternate-day S-1 and lentinan as first-line chemotherapy for unresectable or recurrent gastric cancer
Yoshino, S., Nishimura, T., Sakata, K., Yoshida, S., Furuya, T., Yamamoto, T., Kawaoka, T., Shimizu, R., Sato, T., Matoba, K., Morioka, H., Iida, M., Suzuki, N., Takeda, S., Ueno, T., Hazama, S., NagaVolume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw199.84
Date:
June, 2016
File:
PDF, 64 KB
2016